The story of Stada: a private equity bidding war

Hannah Langworth 11 July 2017

The past year has been an eventful one for German pharmaceuticals business Stada. Pressure from activist investors has led to a long and complex power struggle.

Here

Next article »

« Previous article

Related Articles

End of Year Review: Malcolm Coffin, Inflexion

08/01/24

End of Year Review: Garry Wilson, BVCA & Endless

02/01/24

End of Year Review: Paul Newsome, Unigestion

21/12/23

End of Year Review: Shami Nissan, Actis

20/12/23

GPs shifting interest to infra, secondaries and PC – Moonfare

19/12/23

Private equity derisks debt and reduces leverage multiples – Investec

12/12/23

Search